Literature DB >> 26449133

10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study).

Robyn L McClelland1, Neal W Jorgensen2, Matthew Budoff3, Michael J Blaha4, Wendy S Post4, Richard A Kronmal2, Diane E Bild5, Steven Shea6, Kiang Liu7, Karol E Watson8, Aaron R Folsom9, Amit Khera10, Colby Ayers11, Amir-Abbas Mahabadi12, Nils Lehmann13, Karl-Heinz Jöckel13, Susanne Moebus13, J Jeffrey Carr14, Raimund Erbel12, Gregory L Burke15.   

Abstract

BACKGROUND: Several studies have demonstrated the tremendous potential of using coronary artery calcium (CAC) in addition to traditional risk factors for coronary heart disease (CHD) risk prediction. However, to date, no risk score incorporating CAC has been developed.
OBJECTIVES: The goal of this study was to derive and validate a novel risk score to estimate 10-year CHD risk using CAC and traditional risk factors.
METHODS: Algorithm development was conducted in the MESA (Multi-Ethnic Study of Atherosclerosis), a prospective community-based cohort study of 6,814 participants age 45 to 84 years, who were free of clinical heart disease at baseline and followed for 10 years. MESA is sex balanced and included 39% non-Hispanic whites, 12% Chinese Americans, 28% African Americans, and 22% Hispanic Americans. External validation was conducted in the HNR (Heinz Nixdorf Recall Study) and the DHS (Dallas Heart Study).
RESULTS: Inclusion of CAC in the MESA risk score offered significant improvements in risk prediction (C-statistic 0.80 vs. 0.75; p < 0.0001). External validation in both the HNR and DHS studies provided evidence of very good discrimination and calibration. Harrell's C-statistic was 0.779 in HNR and 0.816 in DHS. Additionally, the difference in estimated 10-year risk between events and nonevents was approximately 8% to 9%, indicating excellent discrimination. Mean calibration, or calibration-in-the-large, was excellent for both studies, with average predicted 10-year risk within one-half of a percent of the observed event rate.
CONCLUSIONS: An accurate estimate of 10-year CHD risk can be obtained using traditional risk factors and CAC. The MESA risk score, which is available online on the MESA web site for easy use, can be used to aid clinicians when communicating risk to patients and when determining risk-based treatment strategies.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atherosclerosis; coronary disease; epidemiology; risk prediction

Mesh:

Year:  2015        PMID: 26449133      PMCID: PMC4603537          DOI: 10.1016/j.jacc.2015.08.035

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  36 in total

Review 1.  Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review.

Authors:  Sanne A E Peters; Hester M den Ruijter; Michiel L Bots; Karel G M Moons
Journal:  Heart       Date:  2011-11-17       Impact factor: 5.994

Review 2.  Added value of CAC in risk stratification for cardiovascular events: a systematic review.

Authors:  Sanne A E Peters; Marina Bakker; Hester M den Ruijter; Michiel L Bots
Journal:  Eur J Clin Invest       Date:  2011-06-06       Impact factor: 4.686

3.  Coronary artery calcium score and risk classification for coronary heart disease prediction.

Authors:  Tamar S Polonsky; Robyn L McClelland; Neal W Jorgensen; Diane E Bild; Gregory L Burke; Alan D Guerci; Philip Greenland
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

4.  Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension: result of the Heinz Nixdorf Recall Study.

Authors:  Raimund Erbel; Nils Lehmann; Stefan Möhlenkamp; Sofia Churzidse; Marcus Bauer; Hagen Kälsch; Axel Schmermund; Susanne Moebus; Andreas Stang; Ulla Roggenbuck; Martina Bröcker-Preuss; Nico Dragano; Christian Weimar; Johannes Siegrist; Karl-Heinz Jöckel
Journal:  Hypertension       Date:  2011-11-28       Impact factor: 10.190

5.  Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality.

Authors:  Stefan Möhlenkamp; Nils Lehmann; Susanne Moebus; Axel Schmermund; Nico Dragano; Andreas Stang; Johannes Siegrist; Klaus Mann; Karl-Heinz Jöckel; Raimund Erbel
Journal:  J Am Coll Cardiol       Date:  2011-03-29       Impact factor: 24.094

6.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study.

Authors:  Raimund Erbel; Stefan Möhlenkamp; Susanne Moebus; Axel Schmermund; Nils Lehmann; Andreas Stang; Nico Dragano; Dietrich Grönemeyer; Rainer Seibel; Hagen Kälsch; Martina Bröcker-Preuss; Klaus Mann; Johannes Siegrist; Karl-Heinz Jöckel
Journal:  J Am Coll Cardiol       Date:  2010-10-19       Impact factor: 24.094

7.  Cardiovascular imaging for assessing cardiovascular risk in asymptomatic men versus women: the multi-ethnic study of atherosclerosis (MESA).

Authors:  Aditya Jain; Robyn L McClelland; Joseph F Polak; Steven Shea; Gregory L Burke; Diane E Bild; Karol E Watson; Matthew J Budoff; Kiang Liu; Wendy S Post; Aaron R Folsom; João A C Lima; David A Bluemke
Journal:  Circ Cardiovasc Imaging       Date:  2010-11-10       Impact factor: 7.792

8.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

Authors:  Joseph Yeboah; Robyn L McClelland; Tamar S Polonsky; Gregory L Burke; Christopher T Sibley; Daniel O'Leary; Jeffery J Carr; David C Goff; Philip Greenland; David M Herrington
Journal:  JAMA       Date:  2012-08-22       Impact factor: 56.272

9.  A comparison of outcomes with coronary artery calcium scanning in unselected populations: the Multi-Ethnic Study of Atherosclerosis (MESA) and Heinz Nixdorf RECALL study (HNR).

Authors:  Matthew J Budoff; Stefan Möhlenkamp; Robyn McClelland; Joseph A Delaney; Marcus Bauer; Heinz Karl Jöckel; Hagen Kälsch; Richard Kronmal; Khurram Nasir; Nils Lehmann; Susanne Moebus; Ken Mukamal; Raimund Erbel
Journal:  J Cardiovasc Comput Tomogr       Date:  2013-06-13

Review 10.  Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are sufficient to define primary prevention treatment strategies among asymptomatic patients.

Authors:  Charlotte Andersson; Ramachandran S Vasan
Journal:  Circ Cardiovasc Imaging       Date:  2014-03       Impact factor: 7.792

View more
  140 in total

Review 1.  Emerging Role of Coronary Computed Tomography Angiography in Lipid-Lowering Therapy: a Bridge to Image-Guided Personalized Medicine.

Authors:  Toru Miyoshi; Kazuhiro Osawa; Keishi Ichikawa; Kazuki Suruga; Takashi Miki; Masashi Yoshida; Koji Nakagawa; Hironobu Toda; Kazufumi Nakamura; Hiroshi Morita; Hiroshi Ito
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

2.  Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium.

Authors:  Leslee J Shaw; James K Min; Khurram Nasir; Joe X Xie; Daniel S Berman; Michael D Miedema; Seamus P Whelton; Zeina A Dardari; Alan Rozanski; John Rumberger; C Noel Bairey Merz; Mouaz H Al-Mallah; Matthew J Budoff; Michael J Blaha
Journal:  Eur Heart J       Date:  2018-11-01       Impact factor: 29.983

Review 3.  Addressing Knowledge Gaps in the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: a Review of Recent Coronary Artery Calcium Literature.

Authors:  Vasanth Sathiyakumar; Roger S Blumenthal; Khurram Nasir; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2017-02       Impact factor: 5.113

4.  Joint Analysis of Multiple Interaction Parameters in Genetic Association Studies.

Authors:  Jihye Kim; Andrey Ziyatdinov; Vincent Laville; Frank B Hu; Eric Rimm; Peter Kraft; Hugues Aschard
Journal:  Genetics       Date:  2018-12-21       Impact factor: 4.562

Review 5.  Multimodality imaging for the prevention of cardiovascular events: Coronary artery calcium and beyond.

Authors:  Duygu Kocyigit; Alexandra Scanameo; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

6.  Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.

Authors:  Anandita Agarwala; Salim Virani; David Couper; Lloyd Chambless; Eric Boerwinkle; Brad C Astor; Ron C Hoogeveen; Joe Coresh; A Richey Sharrett; Aaron R Folsom; Tom Mosley; Christie M Ballantyne; Vijay Nambi
Journal:  Atherosclerosis       Date:  2016-08-25       Impact factor: 5.162

Review 7.  Assessing Cardiovascular Disease Risk and Responses to Preventive Therapies in Clinical Practice.

Authors:  Kevin C Maki; Mary R Dicklin
Journal:  Curr Atheroscler Rep       Date:  2018-03-20       Impact factor: 5.113

Review 8.  Imaging the myocardial ischemic cascade.

Authors:  Arthur E Stillman; Matthijs Oudkerk; David A Bluemke; Menko Jan de Boer; Jens Bremerich; Ernest V Garcia; Matthias Gutberlet; Pim van der Harst; W Gregory Hundley; Michael Jerosch-Herold; Dirkjan Kuijpers; Raymond Y Kwong; Eike Nagel; Stamatios Lerakis; John Oshinski; Jean-François Paul; Riemer H J A Slart; Vinod Thourani; Rozemarijn Vliegenthart; Bernd J Wintersperger
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-19       Impact factor: 2.357

Review 9.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

Review 10.  Coronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT?

Authors:  Joseph Shemesh
Journal:  Ann Transl Med       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.